Organigram Global (OGI) Stock Price, News & Analysis

Company Overview

Organigram Global Inc. is a Canadian cannabis company that develops, produces, and sells cannabis products for adult-use and medical markets. The company’s portfolio includes dried flower, pre-rolls, cannabis-infused beverages, edibles, vapes, concentrates, and other cannabis-derived products.

Organigram markets products under several brands, including Edison Cannabis Co., SHRED, Big Bag O’ Buds, Monjour, Trailblazer, and Holy Mountain. Its products are distributed through Canada’s regulated cannabis retail and medical channels, with the company also pursuing international opportunities in select legal cannabis markets.

Founded in 2013, the company has expanded its production and brand portfolio through internal development and acquisitions. Organigram’s operations have included cultivation, processing, product manufacturing, and research and development, supported by facilities in Canada. Its shares trade on the Nasdaq Capital Market under the symbol OGI.

Key Stats

• Today's Range: $1.07 to $1.10
• 50-Day Range: $0.90 to $1.29
• 52-Week Range: $0.85 to $2.24
• Volume: 236,446 shs
• Average Volume: 512,581 shs
• Market Capitalization: $155.14 million
• P/E Ratio: 2.39
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Organigram Global Stock Analysis - MarketRank™

Organigram Global scored higher than 32% of companies evaluated by MarketBeat, and ranked 791st out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Hold

Consensus Rating

Organigram Global has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Organigram Global has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Organigram Global are expected to grow in the coming year, from ($0.11) to $0.05 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Organigram Global is 2.39, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.94.

Price to Earnings Ratio vs. Sector

The P/E ratio of Organigram Global is 2.39, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.98.

Price to Book Value per Share Ratio

Organigram Global has a P/B Ratio of 0.59. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.46% of the float of Organigram Global has been sold short.

Short Interest Ratio / Days to Cover

Organigram Global has a short interest ratio ("days to cover") of 9.48.

Change versus previous month

Short interest in Organigram Global has recently decreased by 10.59%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Organigram Global does not currently pay a dividend.

Dividend Growth

Organigram Global does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Organigram Global this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

9 people have added Organigram Global to their MarketBeat watchlist in the last 30 days. This is an increase of 80% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Organigram Global insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.09% of the stock of Organigram Global is held by insiders.

Percentage Held by Institutions

34.63% of the stock of Organigram Global is held by institutions.

Company Calendar

• Last Earnings: 5/12/2026
• Today: 9/24/2026
• Fiscal Year End: 9/30/2026
• Investor Day 2026: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:OGI
• CIK: 1620737
• Web: www.organigram.ca
• Phone: (844) 644-4726
• Fax: N/A
• Employees: 1,139
• Year Founded: 2013

Profitability

• EPS (Trailing Twelve Months): $0.46
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$17.70 million
• Net Margins: 28.14%
• Pretax Margin: 26.88%
• Return on Equity: -13.39%
• Return on Assets: -8.67%

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 2.61
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: $185.07 million
• Price / Sales: 0.84
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.86 per share
• Price / Book: 0.59

Miscellaneous

• Outstanding Shares: 141,040,000
• Free Float: 140,910,000
• Market Cap: $155.14 million
• Optionable: Optionable
• Beta: 1.49